Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Patients Treated With Aromatase Inhibitors”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Testing effectiveness (Phase 2)Study completedNCT00066339
What this trial is testing

Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 44
Not applicableStudy completedNCT03096041
What this trial is testing

Phase 3 Study Randomized Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase Inhibitors

Who this might be right for
Musculoskeletal PainBreast Cancer
Centre Francois Baclesse 197
Post-approval studies (Phase 4)UnknownNCT01908556
What this trial is testing

Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace)

Who this might be right for
is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.
Institut fuer Frauengesundheit 3,545
Not applicableStudy completedNCT04498481
What this trial is testing

TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

Who this might be right for
Breast Cancer
Pfizer 1
Testing effectiveness (Phase 2)WithdrawnNCT00935558
What this trial is testing

Dendritic Cell Based Therapy for Breast Cancer Patients

Who this might be right for
Breast Cancer
Inge Marie Svane
Early research (Phase 1)Study completedNCT00508586
What this trial is testing

PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
PTC Therapeutics 33
Post-approval studies (Phase 4)Study completedNCT04705883
What this trial is testing

Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors

Who this might be right for
Vulvar AtrophyBreast CancerGenitourinary Syndrome of Menopause
Hospital Clinic of Barcelona 10
Testing effectiveness (Phase 2)Ended earlyNCT00722072
What this trial is testing

Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
OHSU Knight Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT02970682
What this trial is testing

SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer

Who this might be right for
Breast Neoplasm
Evgen Pharma 60
Testing effectiveness (Phase 2)Study completedNCT00423917
What this trial is testing

Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 36
Not applicableStudy completedNCT06172088
What this trial is testing

Exploratory Study Therapeutic Fasting Reduce Physical Limitations, Quality of Life During Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer Patients Treated With Aromatase Inhibitors
University Hospital Tuebingen 54
Not applicableLooking for participantsNCT04660435
What this trial is testing

To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer

Who this might be right for
Metastatic Breast CancerER Positive Breast CancerHER2-negative Breast Cancer
Fondazione Sandro Pitigliani 150
Testing effectiveness (Phase 2)Ended earlyNCT00498901
What this trial is testing

Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
University of Washington 1
Testing effectiveness (Phase 2)Study completedNCT02866955
What this trial is testing

Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.

Who this might be right for
Breast Cancer
Institut de Cancérologie de Lorraine 100
Not applicableStudy completedNCT01153672
What this trial is testing

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

Who this might be right for
Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer
University of Washington 8
Not applicableStudy completedNCT01081509
What this trial is testing

Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence

Who this might be right for
Breast Cancer
AstraZeneca 1,077
Not applicableStudy completedNCT01928186
What this trial is testing

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more
University of Washington 28
Not applicableStudy completedNCT05569187
What this trial is testing

Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 76
Not applicableLooking for participantsNCT06610565
What this trial is testing

Fasting-mimicking Diet Intervention on Side Effects of Aromatase Inhibitors Treatment in Patients With Breast Cancer

Who this might be right for
Breast Cancer
European Institute of Oncology 60
Testing effectiveness (Phase 2)Study completedNCT00698035
What this trial is testing

Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients

Who this might be right for
Sexual Dysfunction, Physiological
University of California, San Francisco 76
Next Page